NO176232C - Fremgangsmåte for fremstilling av en fast, oral doseringsform med regulert frigivelse av medikament - Google Patents

Fremgangsmåte for fremstilling av en fast, oral doseringsform med regulert frigivelse av medikament

Info

Publication number
NO176232C
NO176232C NO892229A NO892229A NO176232C NO 176232 C NO176232 C NO 176232C NO 892229 A NO892229 A NO 892229A NO 892229 A NO892229 A NO 892229A NO 176232 C NO176232 C NO 176232C
Authority
NO
Norway
Prior art keywords
dosage form
controlled release
oral dosage
drug
preparation
Prior art date
Application number
NO892229A
Other languages
English (en)
Norwegian (no)
Other versions
NO176232B (no
NO892229D0 (no
NO892229L (no
Inventor
Joanne Heafield
Stewart Thomas Leslie
Sandra Therese Antoi Malkowska
Philip John Neale
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of NO892229D0 publication Critical patent/NO892229D0/no
Publication of NO892229L publication Critical patent/NO892229L/no
Publication of NO176232B publication Critical patent/NO176232B/no
Publication of NO176232C publication Critical patent/NO176232C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO892229A 1988-06-02 1989-06-01 Fremgangsmåte for fremstilling av en fast, oral doseringsform med regulert frigivelse av medikament NO176232C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888813064A GB8813064D0 (en) 1988-06-02 1988-06-02 Controlled release dosage forms having defined water content

Publications (4)

Publication Number Publication Date
NO892229D0 NO892229D0 (no) 1989-06-01
NO892229L NO892229L (no) 1989-12-04
NO176232B NO176232B (no) 1994-11-21
NO176232C true NO176232C (no) 1995-03-01

Family

ID=10637952

Family Applications (1)

Application Number Title Priority Date Filing Date
NO892229A NO176232C (no) 1988-06-02 1989-06-01 Fremgangsmåte for fremstilling av en fast, oral doseringsform med regulert frigivelse av medikament

Country Status (19)

Country Link
US (1) US5091189A (ko)
EP (1) EP0344960B1 (ko)
JP (1) JPH0816060B2 (ko)
KR (1) KR0136279B1 (ko)
AT (1) ATE83925T1 (ko)
AU (1) AU610401B2 (ko)
CA (1) CA1323834C (ko)
DE (1) DE68904119T2 (ko)
DK (1) DK175130B1 (ko)
ES (1) ES2053989T3 (ko)
FI (1) FI93695C (ko)
GB (2) GB8813064D0 (ko)
GR (1) GR3007088T3 (ko)
IE (1) IE61998B1 (ko)
IL (1) IL90462A (ko)
NO (1) NO176232C (ko)
NZ (1) NZ229372A (ko)
PT (1) PT90722B (ko)
ZA (1) ZA894201B (ko)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US5912268A (en) * 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
CA2314896C (en) * 1997-12-22 2005-09-13 Euro-Celtique, S.A. A method of preventing abuse of opioid dosage forms
JP2001526228A (ja) 1997-12-22 2001-12-18 ユーロ−セルティーク，エス．エイ． オピオイド作動薬／拮抗薬の併用
AU1738800A (en) 1998-11-23 2000-06-13 Bonnie Davis Dosage formulations for acetylcholinesterase inhibitors
HU229705B1 (en) 2000-02-08 2014-05-28 Euro Celtique Sa Tamper-resistant oral opioid agonist formulations
CN1525851A (zh) 2001-05-11 2004-09-01 ������ҩ�����޹�˾ 抗滥用阿片样物质控释剂型
US7052706B2 (en) * 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
SI1416842T1 (sl) * 2001-07-18 2009-06-30 Euro Celtique Sa Farmacevtske kombinacije oksikodona in naloksona
ATE431738T1 (de) 2001-08-06 2009-06-15 Euro Celtique Sa Opioid-agonist-formulierungen mit freisetzbarem und sequestriertem antagonist
AU2002324624A1 (en) 2001-08-06 2003-02-24 Euro-Celtique S.A. Sequestered antagonist formulations
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
IN192180B (ko) * 2001-09-28 2004-03-06 Ranbaxy Lab
CA2479350A1 (en) * 2002-03-15 2003-09-25 Cypress Bioscience, Inc. Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
EP1492505B1 (en) 2002-04-05 2015-06-03 Euro-Celtique S.A. Pharmaceutical preparation containing oxycodone and naloxone
US7815934B2 (en) 2002-09-20 2010-10-19 Alpharma Pharmaceuticals, Llc Sequestering subunit and related compositions and methods
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
WO2004067039A1 (en) * 2003-01-28 2004-08-12 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US20040202717A1 (en) * 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
MY135852A (en) * 2003-04-21 2008-07-31 Euro Celtique Sa Pharmaceutical products
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
ES2317313T3 (es) * 2004-10-19 2009-04-16 Krka, Tovarna Zdravil, D.D., Novo Mesto Composicion farmaceutica solida que comprende clorhidrato de donepezilo.
EP1702558A1 (en) * 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
EP1942875B1 (en) * 2005-08-24 2015-08-12 Rubicon Research Private Limited Controlled release formulation
SI2719378T1 (sl) 2006-06-19 2016-11-30 Alpharma Pharmaceuticals Llc Farmacevtski sestavki
PL2068816T3 (pl) * 2006-09-29 2018-03-30 The Procter And Gamble Company Kompozycje do higieny jamy ustnej zawierające sieci żelowe
EP2224808A4 (en) * 2007-12-17 2013-11-27 Alpharma Pharmaceuticals Llc PHARMACEUTICAL COMPOSITION
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US8623418B2 (en) * 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
RU2478388C2 (ru) * 2008-07-07 2013-04-10 Еуро-Селтик С.А. Фармацевтическая композиция, содержащая опиоидный антагонист, для лечения задержки мочи
MY152279A (en) 2009-03-10 2014-09-15 Euro Celtique Sa Immediate release pharmaceutical compositions comprising oxycodone and naloxone
US10071089B2 (en) 2013-07-23 2018-09-11 Euro-Celtique S.A. Combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
CN114053235B (zh) * 2020-08-07 2023-07-18 广州白云山光华制药股份有限公司 茶碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
US4443428A (en) * 1982-06-21 1984-04-17 Euroceltique, S.A. Extended action controlled release compositions
FR2535202B1 (fr) * 1982-11-03 1985-08-09 Fabre Sa Pierre Comprimes de theophylline a liberation controlee et leur procede de fabrication
US4743247A (en) * 1984-08-13 1988-05-10 Alza Corporation Process for manufacturing dosage form
US4753800A (en) * 1985-10-04 1988-06-28 Warner-Lambert Company Medicament adsorbates and their preparation
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
DE3750145T2 (de) * 1986-06-10 1994-11-03 Euro Celtique Sa Zusammensetzung mit kontrollierter Freisetzung von Dihydrocodein.
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids

Also Published As

Publication number Publication date
IE891744L (en) 1989-12-02
ZA894201B (en) 1990-03-28
GR3007088T3 (ko) 1993-07-30
DE68904119T2 (de) 1993-06-09
IL90462A0 (en) 1990-01-18
FI93695C (fi) 1995-05-26
KR900000077A (ko) 1990-01-30
DE68904119D1 (de) 1993-02-11
DK175130B1 (da) 2004-06-14
GB8813064D0 (en) 1988-07-06
JPH0225420A (ja) 1990-01-26
JPH0816060B2 (ja) 1996-02-21
AU610401B2 (en) 1991-05-16
NO176232B (no) 1994-11-21
ES2053989T3 (es) 1994-08-01
EP0344960A2 (en) 1989-12-06
DK266889D0 (da) 1989-06-01
IE61998B1 (en) 1994-12-14
FI93695B (fi) 1995-02-15
FI892664L (fi) 1989-12-03
GB2219207B (en) 1992-01-02
ATE83925T1 (de) 1993-01-15
GB8911629D0 (en) 1989-07-05
EP0344960B1 (en) 1992-12-30
NO892229D0 (no) 1989-06-01
IL90462A (en) 1993-01-31
PT90722B (pt) 1994-11-30
US5091189A (en) 1992-02-25
FI892664A0 (fi) 1989-06-01
NZ229372A (en) 1991-07-26
KR0136279B1 (ko) 1998-04-25
AU3512789A (en) 1989-12-07
NO892229L (no) 1989-12-04
EP0344960A3 (en) 1990-03-07
DK266889A (da) 1989-12-03
PT90722A (pt) 1989-12-29
CA1323834C (en) 1993-11-02
GB2219207A (en) 1989-12-06

Similar Documents

Publication Publication Date Title
NO176232C (no) Fremgangsmåte for fremstilling av en fast, oral doseringsform med regulert frigivelse av medikament
DK568687D0 (da) Hydromorphonpraeparat med reguleret afgivelse
IL83363A (en) Use of indol-3-yl-carboxylic acid endo-8-methyl-8-aza- bicyclo (3,2,1) oct-3-yl ester for the preparation of psycho-active pharmaceutical compositions suitable for the treatment of stress- related psychiatric disorders or for increasing vigilance
SE8505099L (sv) Pulver med reglerad frigoring samt sett for framstellning derav
HRP930676B1 (en) Process for the production of an active substance plaster containing estrogen
EP0449247A3 (en) Pharmaceutical composition containing galanthamine for treating alcoholism
ATE107857T1 (de) Zusammensetzung mit kontrollierter freisetzung von dihydrocodein.
EP0068450A3 (en) Pharmaceutical forms for oral administration
PT79786A (fr) Procede de preparation d'1ne matrice inerte a base de polycaprolactone pour administration orale d'un medicament
AU1196988A (en) Process for preparing a retard product containing diltiazem for a single daily administration
GR3007347T3 (ko)
ES500670A0 (es) Procedimiento de preparar farmacos con liberacion programada de materia activa.
FR2518881B1 (fr) Medicaments a base de 26,23-lactones de la 25-hydroxyvitamine d3, utiles notamment pour agir sur la concentration en calcium du serum
HUT53610A (en) Herbicides containing derivatives of 5-(3,4,5,6-tetrahydroftalamid)-cinnamon acid and process for production of the active substances
IT8882523A0 (it) Metodo per l'avanzamento del piede particolarmente nei pedali per velocipedi.
ATE95174T1 (de) 1,4-dihydropyridin-derivate, verfahren zu ihrer herstellung, pharmazeutische zusammensetzung und ihre verwendung.

Legal Events

Date Code Title Description
MK1K Patent expired